Clinical Trial Update: GLORIA-AF Registry Program - Second and Third Phases

View source ↗

Summary

Registry update for GLORIA-AF program (Second and Third Phases) with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Stroke

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Stroke, Atrial Fibrillation | Status: COMPLETED | Results posted: 2021-03-29